NYSE LISTED TEST STOCK FOR CTS AND CQS (CBO) EBITDA (2010 - 2026)
NYSE LISTED TEST STOCK FOR CTS AND CQS (CBO) EBITDA from Jun 30, 2010 to Mar 31, 2026. The TTM NYSE LISTED TEST STOCK FOR CTS AND CQS (CBO) EBITDA is $1.74B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
NYSE LISTED TEST STOCK FOR CTS AND CQS (CBO) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +34.30% |
| 3 Years TTM | +37.80% |
| 5 Years TTM | +16.81% |
| 10 Years TTM | +16.51% |
| All Time TTM | +16.91% |
Annual EBITDA change of NYSE LISTED TEST STOCK FOR CTS AND CQS (CBO)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $535M | -66.34% |
| 2025 | $1.59B | +29.08% |
| 2024 | $1.23B | +1.27% |
| 2023 | $1.22B | +85.24% |
| 2022 | $656M | -32.56% |
| 2021 | $973M | +18.59% |
| 2020 | $821M | +14.98% |
| 2019 | $714M | -11.15% |
| 2018 | $803M | +42.42% |
| 2017 | $564M | +64.65% |
| 2016 | $343M | -6.44% |
| 2015 | $366M | +3.53% |
| 2014 | $354M | +10.43% |
| 2013 | $320M | +16.23% |
| 2012 | $276M | -0.05% |
| 2011 | $276M | +237.33% |
| 2010 | $82M | -60.15% |
| 2009 | $205M | N/A |